Tenderfy

Gene testing and reporting for Ovarian cancer specimens

Hankija
NHS Greater Glasgow and Clyde
Avaldatud
2026-11-19
Tähtaeg
Pole esitatud
Allikad
UK_FTS
Väärtus
Pole esitatud

Kirjeldus

Kirjeldus on allika keeles.

NHS Greater Glasgow and Clyde, Laboratory Genetics requires an end-to-end diagnostic service for FFPE block processing, DNA based Homologous Repair Deficiency (HRD) and BRCA1 and BRCA2 gene testing and reporting for Ovarian cancer specimens. This service is required for approximately 200 tests per annum and the service must be available by 1st December 2026.

CPV: 85145000

Liikmesus

Teadete eelvaated on tasuta. Ametlike teadete ja dokumentide lingid, ehitusload ning isiklik MCP juurdepääs nõuavad aktiivset tasulist liikmesust.

Loe